|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/68 |
| (11) | Patento numeris | 2615183 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13163561.7 |
| Europos patento paraiškos padavimo data | 2009-05-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-07-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-10-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 127816 P | 2008-05-14 | US |
| (72) |
Baker, Joffre, US
Watson, Drew, US
Maddala, Tara, US
Shak, Steven, US
Mauro, David, J., US
Ford, Shirin, K., US
|
| (73) |
Bristol-Myers Squibb Company,
Route 206 & Province Line Road, Princeton, NJ 08543,
US
Genomic Health, Inc., 301 Penobscot Drive, Redwood City, CA 94063, US |
| (54) | Predictors of patient response to treatment with EGF receptor inhibitors |
| Predictors of patient response to treatment with EGF receptor inhibitors |